This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Antibiotics


  • New Antibiotic Could Provide Single-Dose Option
    In the battle against stubborn skin infections, including methicillin-resistant Staphylococcus aureus (MRSA), a new single-dose antibiotic is as effective as a twice-daily infusion given for up to 10 days, according to a large study led by Duke Medicine researchers. ...More
    June 5, 2014 Posted in News
  • Clinical Trial Shows Dalbavancin is as Effective as Vancomycin
    A study published in today's New England Journal of Medicine reports that the antibiotic dalbavancin is as effective as vancomycin, the current standard-of-care antibiotic used to treat serious bacterial skin and skin-structure infections. The study results establish ...More
    June 4, 2014 Posted in News
  • Unlocking the Potential of Bacterial Gene Clusters to Discover New Antibiotics
    Resistance to antibiotics has been steadily rising, posing a threat to public health. Now, a method from Mohammad Seyedsayamdost, an assistant professor of chemistry at Princeton University, may open the door to the discovery of a host of potential drug candidates. The vast ...More
    May 26, 2014 Posted in News
  • Antibiotics Continue to be Prescribed at High Rate for Bronchitis, Contrary to Guidelines
    Despite clear evidence of ineffectiveness, guidelines and more than 15 years of educational efforts stating that the antibiotic prescribing rate for acute bronchitis should be zero, the rate was about 70 percent from 1996-2010 and increased during this time period, ...More
    May 21, 2014 Posted in News
  • Rutgers Receives Up to $26 Million Grant to Lead Development of New Antibiotics
    The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has selected infectious disease expert David Perlin, executive director of the Public Health Research Institute at Rutgers New Jersey Medical School, to lead a major ...More
    April 25, 2014 Posted in News
  • Study of Gut Microbes, Antibiotics: Clues to Improving Immunity in Premature Infants
    Mothers give a newborn baby a gift of germs—microbes that help to kick-start the infant's immune system. But antibiotics, used to fend off infection, may paradoxically interrupt a newborn's own immune responses, leaving already-vulnerable premature babies more ...More
    April 21, 2014 Posted in News
  • Penicillin Redux: Rearming Proven Warriors for the 21st Century
    Penicillin, one of the scientific marvels of the 20th century, is currently losing a lot of battles it once won against bacterial infections. But scientists at the University of South Carolina have just reported a new approach to restoring its combat effectiveness, even ...More
    April 14, 2014 Posted in News
  • IDSA, Pew Charitable Trusts Support Regulatory Pathway for Antibiotic Development
    The Infectious Diseases Society of America (IDSA) and The Pew Charitable Trusts today hailed increasing bipartisan support in Congress to spur antibiotic development and meet the needs of patients facing the growing threat of drug-resistant pathogens. According to chief ...More
    March 25, 2014 Posted in News
  • Small Peptides as Potential Antibiotics
    Small peptides attack bacteria in many different ways and may well become a new generation of antibiotics. Biologists at the Ruhr-Universität Bochum (RUB) have been researching how such peptides kill bacterial cells. “It is quite possible that, in 10 years' time, ...More
    March 25, 2014 Posted in News
  • Switching an Antibiotic On and Off with Light
    Scientists at Karlsruhe Institute of Technology (KIT) and the University of Kiev have produced an antibiotic whose biological activity can be controlled with light. Thanks to the robust diarylethene photoswitch, the antimicrobial effect of the peptide mimetic can be applied ...More
    March 21, 2014 Posted in News